BioNTech

BioNTech

BioNTech is a global next generation immunotherapy company pioneering novel investigative therapies for cancer and other serious diseases. We exploit a wide array of computational discovery and therapeutic modalities with the intent of rapid development of novel biopharmaceuticals. Its diversified portfolio of oncology product candidates aiming to address the full continuum of cancer includes mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies such as antibody-drug conjugates (ADCs) and innovative chimeric antigen receptor (CAR) T cell therapies.

Yes

Yes